APA (7th ed.) Citation

DM, C., RK, G., LA, B., Cook, D. M., Gurugubelli, R. K., & Bero, L. A. (2009). Risk management policy and black-box warnings: A qualitative analysis of US FDA proceedings. Drug Safety, 32(11), 1057. https://doi.org/10.2165/11316670-000000000-00000

Chicago Style (17th ed.) Citation

DM, Cook, Gurugubelli RK, Bero LA, Daniel M. Cook, Rama K. Gurugubelli, and Lisa A. Bero. "Risk Management Policy and Black-box Warnings: A Qualitative Analysis of US FDA Proceedings." Drug Safety 32, no. 11 (2009): 1057. https://doi.org/10.2165/11316670-000000000-00000.

MLA (9th ed.) Citation

DM, Cook, et al. "Risk Management Policy and Black-box Warnings: A Qualitative Analysis of US FDA Proceedings." Drug Safety, vol. 32, no. 11, 2009, p. 1057, https://doi.org/10.2165/11316670-000000000-00000.